Australia TGA ARTG recordAmbulatory insulin infusion pump software, patient-dosing
Australia TGA ARTG Registered Device · Ypsomed Australia Pty Ltd · CamDiab Ltd · Class IIb · Started June 14, 2022
Good Name: Ypsomed Australia Pty Ltd - Ambulatory insulin infusion pump software, patient-dosing
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- June 14, 2022
- Effective Date
- June 14, 2022
- Name
- CamDiab Ltd
- Country
- United Kingdom
- Address
- Level 4 Institute of Metabolic Science Box 289 Addenbrooke's Hospital Hills Road, Cambridge, CB2 0QQ
The App is used to manage glucose levels in people with type I diabetes, aged 1 year and older, using a hybrid closed-loop approach. Additional age restrictions may apply depending on the chosen continuous glucose monitor and insulin pump.
Access comprehensive regulatory information for Ambulatory insulin infusion pump software, patient-dosing in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Ypsomed Australia Pty Ltd, manufactured by CamDiab Ltd in United Kingdom. The device registration started on June 14, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.